文献速递新发突发、热带与寄生虫病

东南亚重症疟疾患者住院时间的竞争风险建模方法及其对医院服务规划的启示

A Competing-Risk Approach for Modeling Length of Stay in Severe Malaria Patients in South-East Asia and the Implications for Planning of Hospital Services.
PubMed 文献 · Clin Infect Dis · 2018-01-01

该研究对东南亚奎宁与青蒿琥酯疟疾试验中1217例成人重症疟疾患者进行竞争风险生存分析,评估住院时间的影响因素。结果显示20%患者死亡,中位出院时间6天;与奎宁相比,青蒿琥酯增加出院发生率(亚分布风险比1.24)并降低死亡发生率(0.60)。入院及住院期间的临床因素影响住院时间,青蒿琥酯可能延长住院时间,规划服务时应予以考虑。

要点

  • 重症疟疾住院患者中位出院时间为6天,20%患者死亡。
  • 与奎宁相比,青蒿琥酯增加出院发生率(亚分布风险比1.24)并降低死亡发生率(0.60)。
  • 低格拉斯哥昏迷评分、高血尿素氮、酸中毒碱剩余、休克或昏迷降低出院累积发生率并增加死亡发生率。

核心结论

  • 入院时及住院期间的临床因素影响重症疟疾患者的住院时间,为改善健康和服务效率提供靶点。
  • 青蒿琥酯有增加住院时间的可能,规划服务时应予以考虑。
  • 院内死亡是出院的竞争风险,在住院时间模型中应加以考虑以减少风险高估和关联错误呈现。

研究设计与样本

  • 对东南亚奎宁与青蒿琥酯疟疾试验中1217例成人重症疟疾患者进行二次竞争风险生存分析。

主要发现

  • 20%患者死亡,其中95.4%在7天内死亡,而出院患者中70.3%在7天内出院。
  • 中位出院时间为6天。
  • 与奎宁相比,青蒿琥酯增加出院发生率(亚分布风险比1.24,95%置信区间1.09-1.40,P=0.001)并降低死亡发生率(0.60,95%置信区间0.46-0.80,P<0.001)。
  • 低格拉斯哥昏迷评分与出院累积发生率降低相关(1.08,95%置信区间1.06-1.11,P<0.001)并与死亡发生率增加相关(0.85,95%置信区间0.82-0.89,P<0.001)。
  • 高血尿素氮与出院累积发生率降低相关(0.99,95%置信区间0.99-0.995,P<0.001)并与死亡发生率增加相关(1.00,95%置信区间1.00-1.01,P=0.012)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Management of severe malaria with limited resources requires comprehensive planning. Expected length of stay (LOS) and the factors influencing it are useful in the planning and optimisation of service delivery. METHODS: A secondary, competing-risk approach to survival analysis was performed for 1217 adult severe malaria patients from the South-East Asia Quinine Artesunate Malaria Trial. RESULTS: Twenty percent of patients died; 95.4% within 7 days compared to 70.3% of those who were discharged. Median time to discharge was 6 days. Compared to quinine, artesunate increased discharge incidence (subdistribution-Hazard ratio, 1.24; [95% confidence interval 1.09-1.40]; P = .001) and decreased incidence of death (0.60; [0.46-0.80]; P < .001). Low Glasgow coma scale (discharge, 1.08 [1.06-1.11], P < .001; death, 0.85 [0.82-0.89], P < .001), high blood urea-nitrogen (discharge, 0.99 [0.99-0.995], P < .001; death, 1.00 [1.00-1.01], P = .012), acidotic base-excess (discharge, 1.05 [1.03-1.06], P < .001; death, 0.90 [0.88-0.93], P < .001), and development of shock (discharge, 0.25 [0.13-0.47], P < .001; death, 2.14 [1.46-3.12], P < .001), or coma (discharge, 0.46 [0.32-0.65], P < .001; death, 2.30 [1.58-3.36], P < .001) decreased cumulative incidence of discharge and increased incidence of death. Conventional Kaplan-Meier survival analysis overestimated cumulative incidence compared to competing-risk model. CONCLUSIONS: Clinical factors on admission and during hospitalisation influence LOS in severe malaria, presenting targets to improve health and service efficiency. Artesunate has the potential to increase LOS, which should be accounted for when planning services. In-hospital death is a competing risk for discharge; an important consideration in LOS models to reduce overestimation of risk and misrepresentation of associations.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Keene CM, Dondorp A, Crawley J, et al. A Competing-Risk Approach for Modeling Length of Stay in Severe Malaria Patients in South-East Asia and the Implications for Planning of Hospital Services. Clin Infect Dis. 2018. PMID: 29562258. doi:10.1093/cid/ciy211

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。